VivoSeq
Other

Prep

0

Pipeline Programs↗

12

Active Trials↗

7

Companies Involved↗

PrEP is an early-stage landscape with 0 programs across 7 companies. The most active players are Changchun GeneScience Pharmaceutical Co., Ltd., Merck & Co., Zurex Pharma, Inc..

Intelligence

Pipeline Metrics

Competitive Density

29/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Changchun GeneScience Pharmaceutical Co., Ltd. logo

Changchun GeneScience Pharmaceutical Co., Ltd.

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalZ

Zurex Pharma, Inc.

0 programs

PreclinicalW

Watson Pharmaceuticals

0 programs

PreclinicalD

DUSA Pharmaceuticals, Inc.

0 programs

PreclinicalP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

75

clinical trials

Completed53 · 71%
Unknown status6 · 8%
Recruiting5 · 7%
Not yet recruiting4 · 5%
Active, not recruiting3 · 4%
Withdrawn3 · 4%
Other1 · 1%

Clinical Trials

Trial Activity

75 trials

PrEPsmart 2-1-1 Pilot
Recruiting·PPublic Health Foundation Enterprises, Inc.·Phase 2·NCT06631365·60 enrolled
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
Recruiting·UUniversity College, London·Phase 1·NCT06815653·40 enrolled
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
Recruiting·—·Phase 4·NCT07218211·100 enrolled
Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM
Recruiting·—·Phase 4·NCT06188442·300 enrolled
MAPS PrEP Van Study
Recruiting·—·Phase 4·NCT06908252·20 enrolled
Express Testing and Same-day Initiation of PrEP Study
Active, not recruiting·HHQ Toronto·N/A·NCT05690815·816 enrolled
Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa
Active, not recruiting·—·Phase 4·NCT07006246·1,900 enrolled
Encouraging Multiple PrEP Options for Women Engaged in PRimary Care
Active, not recruiting·NNorthwestern University·Preclinical·NCT06785038·132 enrolled
A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations
Not yet recruiting·Changchun GeneScience Pharmaceutical Co., Ltd. logoChangchun GeneScience Pharmaceutical Co., Ltd.·Phase 1·NCT06840691·87 enrolled
Betadine vs Sterile Water for Periurethral Preparation
Not yet recruiting·UUniversity of Louisville·Phase 4·NCT07044726·148 enrolled
Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.
Not yet recruiting·AANRS, Emerging Infectious Diseases·Phase 3·NCT06273943·322 enrolled
BetterInfo Tracing Approach to Evaluate HIV PrEP Choices and Use Over Time Among Women in Blantyre, Malawi
Not yet recruiting·JJohns Hopkins Bloomberg School of Public Health·Preclinical·NCT07579754·384 enrolled
Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers
Completed·MMannkind Corporation·Phase 1·NCT01982604·38 enrolled
A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production
Completed·PPrep Biopharm Limited·Phase 1·NCT03198676·20 enrolled
Desensitizers in Reducing Post Tooth Preparation Sensitivity for a Fixed Dental Prosthesis
Completed·UUniversity of Jazan·N/A·NCT04512625·56 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)